K L Heim-Duthoy - Concepedia

Concepedia

Author

K L Heim-Duthoy

Hennepin County Medical Center

Also Known As

K Heim-Duthoy, K L Heim-Duthoy, K. L. Heim-Duthoy, K.L Heim-Duthoy, K.L. Heim-Duthoy, KAREN HEIM-DUTHOY, KAREN L. HEIM-DUTHOY, Karen Heim-Duthoy, Karen L. Heim-Duthoy, Karen L. Heim‐Duthoy

37

Publications

1.2K

Citations

18

H-Index

64

Concepts

All Affiliations

Hennepin County Medical Center University of Minnesota Metabolism and Renal Physiology Twin Cities Orthopedics

KL

About

K L Heim-Duthoy is an author at Hennepin County Medical Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	885
2	Gastroenterology	2	2	107
3	Immunology	2	2	46
4	Medical Laboratory Science	2	2	25
5	Health Sciences	1	1	12

K L Heim-Duthoy

×

23

Publications

1.2K

Citations

18

H-Index

	Year	Citations
The Adverse Impact of Cyclosporine on Serum Lipids in Renal Transplant Recipients Bertram L. Kasiske, Kathryn Tortorice, K L Heim-Duthoy, American Journal of Kidney Diseases Adverse ImpactKidney TransplantKidney TransplantationImmunosuppressive TherapyPharmacology	1991	124
THE RELATIONSHIP BETWEEN CYCLOSPORINE PHARMACOKINETIC PARAMETERS AND SUBSEQUENT ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTS Bertram L. Kasiske, K L Heim-Duthoy, K. Venkateswara Rao, Transplantation Transplant RejectionUrologyTransplantationKidney TransplantCsa Kinetic Parameters	1988	112
Apparent biliary pseudolithiasis during ceftriaxone therapy K L Heim-Duthoy, Erskine M. Caperton, Rob Pollock, Antimicrobial Agents and Chemotherapy Ceftriaxone TherapyEus-guided Gallbladder DrainageBiliary PseudolithiasisMedicineBiliary Tract	1990	95
THE EFFECTS OF LIPID-LOWERING AGENTS ON ACUTE RENAL ALLOGRAFT REJECTION1, 2 Bertram L. Kasiske, K L Heim-Duthoy, Gary G. Singer, Transplantation	2001	95
Elective cyclosporine withdrawal after renal transplantation. A meta-analysis. B L Kasiske, K L Heim-Duthoy, J Z PubMed Transplantation MedicinePharmacotherapyRenal TransplantationClinical TrialsGraft Survival	1993	94
The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function* Heather Johnson, Suzanne K. Swan, K L Heim-Duthoy, Clinical Pharmacology & Therapeutics Dialysis TherapyPharmacotherapyPharmacokineticsMycophenolate MofetilRenal Function	1998	84
Patients With a Low Income Have Reduced Renal Allograft Survival Roberto S. Kalil, K L Heim-Duthoy, Bertram L. Kasiske American Journal of Kidney Diseases HemodialysisUrologyTransplantationKidney TransplantKidney Transplantation	1992	81
Elective Cyclosporine Withdrawal 1 Year After Renal Transplantation K L Heim-Duthoy, Kerri K. Chitwood, Kathryn Tortorice, American Journal of Kidney Diseases UrologyTransplantationKidney TransplantKidney TransplantationRenal Transplantation	1994	61
Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: Effects of binding and metabolism Walid M. Awni, Bertram L. Kasiske, K L Heim-Duthoy, Clinical Pharmacology & Therapeutics	1989	59
LOVASTATIN TREATMENT OF HYPERCHOLESTEROLEMIA IN RENAL TRANSPLANT RECIPIENTS Bertram L. Kasiske, Kathryn Tortorice, K L Heim-Duthoy, Transplantation	1990	57

Page 1